Zoetis, an industry leader in animal health, has seen substantial growth in revenues, EBITDA margins, and market share over the last decade. The company’s profitability, scale, diversity, and reach ...

New Survey Shows That Over 90% of Animal Owners Trust and Appreciate Veterinary Teams but Underestimate the Demands of the Profession ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration and global license ...

Company prepares new product launches starting in 2025.

The "Enterprise Tech Ecosystem Series: Boehringer Ingelheim 2025" company profile has been added to ResearchAndMarkets.com's offering. Boehringer Ingelheim International: Leading the Way in ...

We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...

Auto-brewery syndrome produces symptoms of intoxication when ethanol produced by dysregulated gut microbiota exceeds the ...

The S&P 500 rose 0.13% to close at 5,282.70 on Thursday (April 17) after a volatile trading session, though the index still ended the holiday-shortened week in the red amid ongoing concerns over ...

— HB Strategies is just the second outside firm on retainer for the Chamber, with Fulcrum Public Affairs as the other. The ...

The latest report published by Report Ocean, titled “Global Active Pharmaceutical Ingredients (API) Market“:Industry Trends, Share, Size, Growth, Opportunity, and Forecast 202 ...

At the heart of the licensing deal is CUE-501, a bispecific molecule that can selectively deplete B cells to address ...